$0.6550
-0.0024-0.37%
Dern. MÀJ: Nov 16, 10:54 AM

The average analyst price target for Dare Bioscience is $14.20, 2067.9% above the current price. Of 5 analysts, 5 rate it Buy. Targets range from $2 to $36. The latest change came on Oct 26, 2026, when Ladenburg Thalmann assumed coverage of Dare Bioscience with a Buy rating and a $2 price target.
Price Target Range — 7 Quarters
Analyst Consensus — 5 Analysts
Rating Trend — Last 9 Months